Respiratory Syncytial Virus Diagnostic Testing Market is Expected to Accelerate at a Whopping 8.8% CAGR, Reaching US$ 1.9 Billion by 2031 | Transparency Market Research

The global 𝐫𝐞𝐬𝐩𝐢𝐫𝐚𝐭𝐨𝐫𝐲 𝐬𝐲𝐧𝐜𝐲𝐭𝐢𝐚𝐥 𝐯𝐢𝐫𝐮𝐬 (𝐑𝐒𝐕) 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭, valued at US$ 884.9 million in 2022, is anticipated to experience robust growth, projected to achieve a CAGR of 8.8% from 2022 to 2031, surpassing US$ 1.9 billion by 2031.

This growth trajectory is attributed to heightened awareness of RSV infection, particularly in developed nations, and the increasing necessity for early detection. The emergence of COVID-19 has further fueled demand for respiratory diagnostic tests, while the rising prevalence of RSV among vulnerable demographics such as the elderly and young children is expected to propel market advancement. Nonetheless, challenges such as the high cost of RSV diagnostic tests and limited awareness in developing regions may impede industry expansion in the coming years.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2065&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

Respiratory syncytial virus (RSV) is a highly contagious virus that primarily affects the respiratory tract (lungs and breathing passages). It is a common cause of upper and lower respiratory infections in infants, young children, and elderly people. The infection can lead to severe complications such as pneumonia and bronchiolitis.

Currently, no specific treatment is available for RSV. However, symptoms can be managed with supportive care. Prevention measures include good hygiene practices, such as frequent hand washing, and avoiding close contact with infected individuals.

𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐝:

F. Hoffmann-La Roche AG,Abbott,Thermo Fisher Scientific,BD (Becton, Dickinson and Company),QuidelOrtho Corporation,Hologic, Inc.,Luminex Corporation,Agilent Technologies, Inc.,Cepheid (Danaher Corporation),DiaSorin S.p.A.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

𝐓𝐞𝐬𝐭 𝐓𝐲𝐩𝐞

Antigen Detection Test
Molecular Diagnostic Test
Direct Fluorescent Antibody Test
Diagnostic Imaging
Others

𝐏𝐫𝐨𝐝𝐮𝐜𝐭

Kits and Assays
Instruments/Devices

𝐄𝐧𝐝-𝐮𝐬𝐞𝐫

Hospitals-attached Laboratories
Independent Diagnostic Laboratories
Others

𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬:

In October 2022, F. Hoffmann-La Roche AG received the U.S. Food and Drug Administration approval for the cobas SARS-CoV-2 Qualitative PCR test for use on the fully automated cobas 6800 and cobas 8800 Systems

In November 2021, F. Hoffmann-La Roche AG launched cobas 5800 System, a new molecular laboratory instrument, in countries accepting the CE mark

𝐆𝐞𝐭 𝐓𝐡𝐢𝐬 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭, 𝐈𝐧𝐬𝐭𝐚𝐧𝐭𝐥𝐲:
https://www.transparencymarketresearch.com/checkout.php?rep_id=2065<ype=S&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐑𝐞𝐠𝐢𝐨𝐧𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝:

North America(USA, Canada and Mexico)
Europe(UK, Germany, France and the Rest of Europe)
Asia Pacific(China, Japan, India, and the Rest of the Asia Pacific region)
South America(Brazil, Argentina and the Rest of South America)
Middle East and Africa(GCC and Rest of the Middle East and Africa)

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

Key trends include the increasing adoption of point-of-care testing, technological advancements in diagnostic techniques, and strategic collaborations among market players to expand their product portfolios.

𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

The future of the RSV diagnostic testing market looks promising, with opportunities for innovation and expansion in untapped regions. Continued efforts to enhance affordability and accessibility of diagnostic tests will further drive market growth.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬:

Market size and growth projections
Regional dynamics and emerging markets
Competitive landscape and key players
Market drivers and challenges
Technological advancements and innovations
Regulatory landscape and compliance

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐆𝐫𝐚𝐝𝐞 𝐏𝐥𝐚𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/05/11/2667120/0/en/Global-Medical-Grade-Plastics-Market-to-Rise-at-Over-7-CAGR-from-2022-to-2031-Reaching-a-Valuation-of-US-76-6-Billion-TMR-Report.html

𝐇𝐢𝐩 𝐑𝐞𝐩𝐥𝐚𝐜𝐞𝐦𝐞𝐧𝐭 𝐈𝐦𝐩𝐥𝐚𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/05/11/2666947/0/en/Hip-Replacement-Implants-Market-is-Likely-to-Reach-USD-7-0-Bn-by-2031-growing-with-CAGR-of-4-0-TMR-Study.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com        
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.